barr 250mg 589 Pill - blue & white capsule/oblong, 19mm
Pill with imprint barr 250mg 589 is Blue & White, Capsule/Oblong and has been identified as Didanosine 250 mg. It is supplied by Teva Pharmaceuticals USA.
Didanosine is used in the treatment of Nonoccupational Exposure; HIV Infection and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). There is no proven risk in humans during pregnancy. Didanosine 250 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for barr 250mg 589


Didanosine
- Imprint
- barr 250mg 589
- Strength
- 250 mg
- Color
- Blue & White
- Size
- 19.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Nucleoside reverse transcriptase inhibitors (NRTIs)
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Teva Pharmaceuticals USA
- Inactive Ingredients
-
ferrosoferric oxide,
croscarmellose sodium,
D&C Yellow No. 10,
FD&C Blue No. 1,
FD&C Blue No. 2,
indigotindisulfonate sodium,
FD&C Red No. 40,
hypromellose 2910 (3 mPa.s),
hypromellose 2910 (6 mPa.s),
hypromellose 2910 (50 mPa.s),
methacrylic acid - ethyl acrylate copolymer (1:1) type a,
microcrystalline cellulose,
polydextrose,
polyethylene glycol 8000,
propylene glycol,
shellac,
silicon dioxide,
sodium hydroxide,
magnesium silicate,
titanium dioxide,
triacetin,
triethyl citrate,
D&C Red No. 28
Note: Inactive ingredients may vary.
Labelers / Repackagers
NDC Code | Labeler / Repackager |
---|---|
00555-0589 (Discontinued) | Barr Laboratories, Inc. |
54569-5642 (Discontinued) | A-S Medication Solutions, LLC (repackager) |
54868-5464 (Discontinued) | Physicians Total Care Inc. (repackager) |
More about didanosine
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: nucleoside reverse transcriptase inhibitors (NRTIs)
- Breastfeeding
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.